Abstract
Leuenbergeria bleo (Kunth) DC. (Cactaceae), previously classified as Pereskia bleo, represents a phylogenetically basal cactus species with a disjunct distribution across Central America, Southeast Asia, and southern China. Phytochemical investigations have traditionally emphasized small-molecule secondary metabolites, including phenolics, alkaloids, and terpenoids, which contribute to antioxidant and anti-cancer activities. However, recent peptidomic analyses have expanded this chemical space through the discovery of bleogens, a family of hyper-stable, cysteine-rich microproteins with specific antifungal and wound-healing properties. This review systematically integrates botanical characteristics, ethnomedicinal applications, and pharmacological profiles, providing a comparative analysis of the plant’s small-molecule constituents versus its peptidyl biologics. It identifies the co-existence of these distinct chemical classes as a defining feature of the plant’s efficacy while highlighting the need for future research into their potential interactions.
| Original language | English |
|---|---|
| Article number | 692 |
| Journal | Processes |
| Volume | 14 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Feb 2026 |
Keywords
- Leuenbergeria bleo
- Pereskia bleo
- bleogens
- cysteine-rich peptides
- pharmacological activities
- phytochemistry
- traditional medicine
- wound-healing
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver